EquiReason

EquiReason research coverage

NVIDIA Corporation NVDA

Technology · Semiconductors

24quarters analysed
12SEC filings read
2segments identified
19institutional managers tracked

Segments it reports

The business segments NVIDIA Corporation reports in its own SEC filings.

  • Compute And Networking Segment
  • Graphics Segment

Product lines it reports

The product and service lines NVIDIA Corporation breaks its revenue into.

  • Compute
  • Networking
  • Gaming
  • Professional Visualization
  • Automotive
  • OEM And Other

Where its revenue is reported

The geographies NVIDIA Corporation reports revenue for. How much comes from each is in the product.

  • United States
  • Taiwan
  • China Including Hong Kong
  • Other Countries

What we read

The sources behind this company, and how many records of each we hold.

  • Financial statements25
  • Quarterly metric series12
  • Business segments2
  • SEC filings12
  • Deals and transactions1
  • Insider transactions (Form 4)6
  • Institutional positions (13F)7
  • Earnings events1
  • Earnings quality checks8
  • Estimate revisions11
  • Seasonal pattern6
  • Multi-period trajectory7
  • Inflection detection1
  • Fiscal calendar1
  • Index membership4

What we look for

Every company is run through the same checks. Both answers are reported — a signal we looked for and did not find is as much a fact as one we did.

  • Guidance changes6
  • Revenue series24
  • Margin series11
  • Cash flow series24
  • Earnings series24
  • Per-share series7
  • Operating cash flow series24

This page says how much of NVIDIA Corporation we have read. What any of it means — the direction, the dates, the evidence and what would overturn it — is inside the product.

Open NVDA in EquiReason

This page publishes coverage counts and reported breakdown names, but no financial figures, price data, rankings or investment conclusions. Sources are SEC filings, earnings calls and public institutional disclosures. How the research is made · All companies

NVIDIA Corporation (NVDA) — research coverage | EquiReason